3rd Quarter - Report

MAYO CLINIC for MAYO CLINIC

Firm
Client
Income
—
Expenses
$230,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Science/Technology SCI

Remote Care Technology; Medical Device Technologies; New Diagnostic Tests

LobbyistCovered position, as disclosed
JENNIFER MALLARD —

Contacted: HOUSE OF REPRESENTATIVES; Transportation, Dept of (DOT); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE

Railroads RRR

High Speed Rail; Freight Rail Corridor.

LobbyistCovered position, as disclosed
JENNIFER MALLARD —

Contacted: Transportation, Dept of (DOT); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Hospital payments; Physician payments; Healthcare grants; Medical Record Privacy; Compounding Pharmacy

LobbyistCovered position, as disclosed
JENNIFER MALLARD —

Contacted: SENATE; Food & Drug Administration (FDA); Transportation, Dept of (DOT); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Teaching hospital payments; ACOs; CMS CMMI; Quality Issues

LobbyistCovered position, as disclosed
JENNIFER MALLARD —

Contacted: Transportation, Dept of (DOT); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA)

Medical/Disease Research/Clinical Labs MED

Lab Payments; Lab Oversight; Research Funding

LobbyistCovered position, as disclosed
JENNIFER MALLARD —

Contacted: Transportation, Dept of (DOT); SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.